#ulcerative proctitis

[iamtheendofrainbow]

Woke up and ate a peanut butter and jam sandwich which made me feel sick (I suffer from UC) - it usually doesn't. Tried to get to work by tram (because I can't just not go because capitalism and social pressure to be efective and hard-working) and of course I had to stand for 20 minutes because I can't just sit down when an elderly person is standing next to me because social pressure, also I am young so I must be healthy and strong so why wouldn't I give up my seat to someone older thus obviously sicker because age determines health.

Youg does NOT mean healthy.

Old does NOT mean sickly.

I wish society would stop putting pressure on young people to feel obliged to give up their seats to others if they don't feel like doing so. Sometimes we are just sick and tired too.

[dr-smita-goel-homeopathy-clinic]

*Dr. Smita Goel Homeopathy Clinic*

www.thehomeopathyclinic.co.in

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.

Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission.

Symptoms

Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:

• Diarrhea, often with blood or pus

• Abdominal pain and cramping

• Rectal pain

• Rectal bleeding — passing small amount of blood with stool

• Urgency to defecate

• Inability to defecate despite urgency

• Weight loss

• Fatigue

• Fever

• In children, failure to grow

Most people with ulcerative colitis have mild to moderate symptoms. The course of ulcerative colitis may vary, with some people having long periods of remission.

Types

Doctors often classify ulcerative colitis according to its location. Types of ulcerative colitis include:

• Ulcerative proctitis: Inflammation is confined to the area closest to the anus (rectum), and rectal bleeding may be the only sign of the disease. This form of ulcerative colitis tends to be the mildest.

• Proctosigmoiditis: Inflammation involves the rectum and sigmoid colon (lower end of the colon). Signs and symptoms include bloody diarrhea, abdominal cramps and pain, and an inability to move the bowels in spite of the urge to do so (tenesmus).

• Left-sided colitis: Inflammation extends from the rectum up through the sigmoid and descending colon. Signs and symptoms include bloody diarrhea, abdominal cramping and pain on the left side, and unintended weight loss.

• Pancolitis: Pancolitis often affects the entire colon and causes bouts of bloody diarrhea that may be severe, abdominal cramps and pain, fatigue, and significant weight loss.

• Acute severe ulcerative colitis: This rare form of colitis affects the entire colon and causes severe pain, profuse diarrhea, bleeding, fever and inability to eat.

When to see a doctor

See your doctor if you experience a persistent change in your bowel habits or if you have signs and symptoms such as:

• Abdominal pain

• Blood in your stool

• Ongoing diarrhea that doesn't respond to over-the-counter medications

• Diarrhea that awakens you from sleep

• An unexplained fever lasting more than a day or two

Although ulcerative colitis usually isn't fatal, it's a serious disease that, in some cases, may cause life-threatening complications.

Causes

The exact cause of ulcerative colitis remains unknown. Previously, diet and stress were suspected, but now doctors know that these factors may aggravate but don't cause ulcerative colitis.

One possible cause is an immune system malfunction. When your immune system tries to fight off an invading virus or bacterium, an abnormal immune response causes the immune system to attack the cells in the digestive tract, too.

Heredity also seems to play a role in that ulcerative colitis is more common in people who have family members with the disease. However, most people with ulcerative colitis don't have this family history.

Risk factors

Ulcerative colitis affects about the same number of women and men. Risk factors may include:

• Age: Ulcerative colitis usually begins before the age of 30. But, it can occur at any age, and some people may not develop the disease until after age 60.

• Race or ethnicity: Although whites have the highest risk of the disease, it can occur in any race. If you're of Ashkenazi Jewish descent, your risk is even higher.

• Family history: You're at higher risk if you have a close relative, such as a parent, sibling or child, with the disease.

Complications

Possible complications of ulcerative colitis include:

• Severe bleeding

• A hole in the colon (perforated colon)

• Severe dehydration

• Liv0065Rr disease (rare)

• Bone loss (osteoporosis)

• Inflammation of your skin, joints and eyes

• An increased risk of colon cancer

• A rapidly swelling colon (toxic megacolon)

• Increased risk of blood clots in veins and arteries

[mcatmemoranda]

Clinical features – Ulcerative colitis is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon. It commonly involves the rectum and may extend in a proximal and continuous fashion to involve other parts of the colon.

Patients with ulcerative colitis usually present with diarrhea, which is frequently associated with blood. Associated symptoms include colicky abdominal pain, urgency, and tenesmus. Patients with mainly distal disease may have constipation accompanied by frequent discharge of blood and mucus.

Patients may also have fever, fatigue, and weight loss. Ulcerative colitis primarily involves the intestine but may be associated with several extraintestinal manifestations.

●When to suspect ulcerative colitis – Ulcerative colitis should be suspected in patients with chronic diarrhea for more than four weeks. The clinical presentation, including laboratory features, endoscopic appearance, and radiology findings, is not specific for ulcerative colitis, and may be seen in a number of other causes of colitis including Crohn disease, radiation colitis, ischemic colitis, infectious colitis, and colitis related to medications.

●Establishing the diagnosis – The diagnosis of ulcerative colitis is based on the presence of diarrhea for more than four weeks and evidence of chronic colitis on endoscopy and biopsy. Since these features are not specific for ulcerative colitis, establishing the diagnosis also requires the exclusion of other causes of colitis by history, laboratory studies, and by biopsies of the colon.

●Disease course – Patients with ulcerative colitis usually present with attacks of bloody diarrhea that lasts for weeks to months. The course of ulcerative colitis typically consists of intermittent exacerbations alternating with periods of complete symptomatic remission. However, a small percentage of patients have continuing symptoms and are unable to achieve remission. Overall, patients who present initially with proctitis have a more benign disease course and frequently respond to topical therapy, whereas those who present with more extensive disease require systemic therapy and have a higher risk of colectomy.

Extension of colonic disease is seen in up to 20 percent of patients within five years. Approximately 67 percent of patients have at least one relapse within 10 years following the diagnosis. The risk of relapse depends on the age at initial diagnosis. The likelihood and timing of colectomy depends on the extent of the disease and severity at presentation. Mucosal healing in response to treatment is an important predictor of long-term clinical outcomes.

●Complications – Complications associated with ulcerative colitis include severe bleeding, toxic megacolon, perforation, strictures, and the development of dysplasia and colorectal cancer. Patients with ulcerative colitis may have a slightly higher mortality as compared with the general population.

Defining disease severity and risk – Patients with mild to moderate ulcerative colitis (UC) are identified as low risk based on prognostic factors that suggest a nonaggressive form of disease: absence of deep mucosal ulcerations, no extraintestinal manifestations, and diagnosis at age >40 years. These patients usually have mild to moderate symptoms (≤6 stools daily with or without blood) and lack signs of systemic inflammation (ie, normal or minimal elevation in C-reactive protein and/or fecal calprotectin levels).

●Pretreatment evaluation – For patients with UC who present with symptoms of a disease flare (eg, diarrhea, rectal bleeding), some aspects of the initial evaluation (eg, laboratory and stool studies, lower endoscopy) are repeated to exclude other conditions as a cause for symptoms and to assess the extent and severity of disease.

●Goals of therapy – The treatment goal for patients with active UC is to achieve clinical and endoscopic remission by demonstrating complete mucosal healing. Response to therapy can be determined by assessing symptoms and laboratory testing and can be supplemented by endoscopy with biopsies as needed.

●Induction therapy for ulcerative proctitis or proctosigmoiditis – For low-risk patients with ulcerative proctitis or proctosigmoiditis, we suggest topical (rectal) mesalamine rather than oral mesalamine or observation (table 1) (Grade 2B). However, for patients who prefer to avoid the burden of daily topical treatment, it is also reasonable to use oral mesalamine or to observe and initiate treatments if disease progresses.

For patients with mild to moderate disease confined to the rectum, we typically initiate treatment with mesalamine suppository once daily (algorithm 1). For patients with mild to moderate disease extending above 18 cm from anal verge into the sigmoid colon, we treat with mesalamine enema once or twice daily.

For low-risk patients with ulcerative proctitis or proctosigmoiditis who do not have symptom improvement after four weeks of topical mesalamine therapy, subsequent options include adding a topical glucocorticoid (eg, suppository, enema), adding an oral 5-aminosalicylic acid (5-ASA) agent, and/or starting an oral glucocorticoid (eg, budesonide multimatrix). Selection of second-line therapy depends on patient preferences, product availability, clinician preferences, and prior response to therapy.

●Induction therapy for left-sided or extensive UC – For low-risk patients with left-sided or extensive mild to moderate UC, we suggest a combination of an oral 5-ASA agent plus rectal mesalamine for induction therapy rather than oral 5-ASA monotherapy (Grade 2B). We begin high-dose oral mesalamine (ie, >3 grams daily) and mesalamine enemas once daily.

●Maintenance therapy – We suggest long-term maintenance therapy for the following low-risk patients who have achieved clinical remission with medical therapy (Grade 2B):

•Patients with ulcerative proctitis and >1 disease flare per year

•Patients with ulcerative proctosigmoiditis

•Patients with UC proximal to the sigmoid colon (i.e., left-sided colitis and extensive colitis)

The choice of maintenance therapy depends on the specific agent used to induce remission, the distribution of disease, patient preferences, clinician preferences, and insurance coverage/cost. For low-risk patients with mild to moderate UC in remission, the goal of management is to prevent clinical and endoscopic relapse.

●Health maintenance – Routine health maintenance, including screening for and prevention of other diseases as well as monitoring for adverse effects of therapy, is an important aspect of the care of patients with inflammatory bowel disease. 

[dr-smitagoelhomeopathyclinic]

*Dr. Smita Goel Homeopathy Clinic*

www.thehomeopathyclinic.co.in

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.

Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission.

Symptoms

Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:

• Diarrhea, often with blood or pus

• Abdominal pain and cramping

• Rectal pain

• Rectal bleeding — passing small amount of blood with stool

• Urgency to defecate

• Inability to defecate despite urgency

• Weight loss

• Fatigue

• Fever

• In children, failure to grow

Most people with ulcerative colitis have mild to moderate symptoms. The course of ulcerative colitis may vary, with some people having long periods of remission.

Types

Doctors often classify ulcerative colitis according to its location. Types of ulcerative colitis include:

• Ulcerative proctitis: Inflammation is confined to the area closest to the anus (rectum), and rectal bleeding may be the only sign of the disease. This form of ulcerative colitis tends to be the mildest.

• Proctosigmoiditis: Inflammation involves the rectum and sigmoid colon (lower end of the colon). Signs and symptoms include bloody diarrhea, abdominal cramps and pain, and an inability to move the bowels in spite of the urge to do so (tenesmus).

• Left-sided colitis: Inflammation extends from the rectum up through the sigmoid and descending colon. Signs and symptoms include bloody diarrhea, abdominal cramping and pain on the left side, and unintended weight loss.

• Pancolitis: Pancolitis often affects the entire colon and causes bouts of bloody diarrhea that may be severe, abdominal cramps and pain, fatigue, and significant weight loss.

• Acute severe ulcerative colitis: This rare form of colitis affects the entire c

[sahajhospital]

Is HBOT Therapy Right for You? A Comprehensive Guide to Treatment

Oxygen is an inevitable vital for human survival. The air that you breathe daily is a homogenous mixture of many gaseous substances, such as nitrogen (N2) 78%, oxygen (O2) 21%, 1% other gases, and water vapor. The nitrogen, when breathed, does not participate in respiration and comes out as it is. Of the 21% oxygen, 16% is exhaled back with an additional 4% carbon dioxide. Only the amount of oxygen needed is retained in the body.

What is HBOT?

HBOT, or hyperbaric oxygen therapy, is the treatment of 97% to 100% oxygen filled in a specialized hitech oxygen chamber at an air pressure of 1.5 to 2 times the usual. This therapy allows the individual to breathe in pure oxygen under pressure. As per Boyle’s law, the oxygen molecules become smaller under hyperbaric pressure making it more soluble. In the case of tissue injuries, the oxygen molecules dissolved in the plasma and other body fluids are directly responsible for formation of new blood vessels and the growth of new tissues. It has several other benefits that we will discuss further in this blog post. The agency of food and drug administration (FDA) of United states (USA) has cleared the use of HBOT as safe and effective. HBOT Therapy treatment started in the 1940s to treat the decompression sickness of deep-sea divers of the U.S. Navy. At the primary stages, the HBOT was also used to treat carbon monoxide poisoning. The scope of using Hyperbaric Oxygen therapy has broadened over time.

How is Hyperbaric Oxygen Therapy helpful?

• HBOT fills your blood with a significantly high amount of oxygen, making it reach the remotest tissues and cells of the body. • Increased oxygen in the blood boosts the wound healing of surgical procedures, infected wounds, skin grafts, burns, and crush injuries and non-healing amputation stump. • It stimulates the production of collagen protein, which is the primary building block of our skin, muscles, bones, ligaments, and many other connective tissues. • HBOT can prevent severe tissue damage to oxygen-deprived tissues. • It also increases the body’s resistance to infections and blocks harmful bacteria. • HBOT also helps in treating radiation injuries, such as the damage after radiation therapy for treating cancer. • In HBOT chamber, 60 times more oxygen is dissolved in plasma & body fluids.

What diseases can be treated by HBOT?

Hyperbaric chamber treatment can help in treating the following medical conditions:

• Ortho-general diseases like diabetic foot, necrotizing fasciitis, compartment syndrome, pressure ulcers and Gas Gangrene. • Neurological diseases like head injuries, Stroke, Autism, intracranial abscess, cerebral palsy, spinal cord contusion, Trigeminal neuralgia and Bell’s palsy. • Ophthalmological diseases like central retinal artery occlusion (sudden vision loss) and Optic neuritis. • Oncological conditions like Post radiation cystitis, post radiation proctitis, mandibular osteoradionecrosis, prophylactic HBOT before radiation treatment and post radiation non healing wounds. • ENT conditions like sudden sensorineural hearing loss, malignant

HBOT and Sahaj Hospital

Sahaj Hospital has always been ahead in technology and has been providing accommodation for hyperbaric oxygen therapy since 2020, soon after the introduction of the COVID-19 virus. Currently, Sahaj is having a monobaric unit of hi-tech and comfortable hyperbaric oxygen chamber. It has been placed in a dedicated and sophisticated place for safety purposes where the attendants are allowed to observe the patient.

Sahaj has done more than 1000+ cases of HBOT until now.

We will now answer some FAQs about the accommodation of Hyperbaric Chamber treatment.

How many sessions of HBOT can I take in a month?

The number of sessions may vary depending on the condition being treated.

What are some pre-HBOT precautions?

You must not carry anything that contains flammable things, lighters, matches, or anything with batteries or gases.

- Wear 100% cotton clothes because it doesn’t generate static electricity to reduce the risk of sparks and fire.

- Avoid drinking alcohol or carbonated drinks before the treatment.

- Avoid if you have flu or a cold.

- No mobile phones, watches, glasses, contacts, or jewelry are allowed inside the chamber.

What is the duration of an HBOT therapy session?

The usual duration of an HBOT session is 60–70 minutes or more, depending on the plan.

Can people with asthma take HBOT?

Yes, if the condition is not chronic; it depends on the patient’s condition and physical fitness.

Can pregnant women take HBOT?

HBOT therapy is not recommended for pregnant women considering the complications that may occur due to the pressure of the chamber.

What are the side effects of the HBOT therapy?

There are usually no side effects but mild clogging of the ear or nose; the effects may vary person to person.

Can my ears rupture under the pressure of an HBOT chamber?

The HBOT is done under careful supervision and examination, so the chances are too slim to consider.

What malfunctions may occur during the HBOT therapy?

Sahaj uses flagship-level high-end machines, so there is nearly no scope for malfunctions.

Can people with claustrophobia take the HBOT therapy?

People with claustrophobia may have trouble facing the closed chamber. But at Sahaj, acutely feared people can take HBOT as the upper half of the chamber is transparent and see through.

What precautions should be kept in mind after an HBOT session?

Nothing as such; you may get back to your usual lifestyle after the sessions.

What are the chances of getting oxygen toxicity during HBOT sessions?

Oxygen toxicity is taking too much highly concentrated oxygen which may happen in sessions too long in rare cases, we limit our sessions to 60–70 minutes which is too far from being risky.

What are the emergency protocols for HBOT treatment?

The HBOT chamber comes with an accessible emergency switch that can be pressed from inside. The chamber room as well is equipped with disaster management for electric and fire hazards, limiting the chances of any unfortunate disaster to zero.

Do we cover insurance?

Yes, HBOT therapy is covered depending on your disease, if HBOT is prescribed by your doctor and if it is covered by your insurance at the same time. It depends on your policy terms and conditions. Most insurances cover the FDA approved 14 defined conditions and many more off label conditions that your insurance may or may not cover.

[blog-site-for-market-research]

Emerging Trends and Opportunities in the Ulcerative Colitis Market

Market Overview –

The size of the ulcerative colitis market was estimated at USD 7.2 billion in 2022 and is expected to increase at a compound annual growth rate (CAGR) of 5.1% between 2023 and 2032, from USD 7.5744 billion in 2023 to USD 10.77 billion.

The Ulcerative Colitis (UC) market pertains to a chronic inflammatory bowel disease characterized by inflammation and ulceration of the colon and rectum. UC significantly impacts patients' quality of life, causing symptoms such as abdominal pain, diarrhea, rectal bleeding, and fatigue. The market offers various treatment options, including aminosalicylates, corticosteroids, immunomodulators, biologics, and surgical interventions, aimed at inducing and maintaining remission and preventing disease complications.

The ulcerative colitis market is experiencing significant growth as awareness of this chronic inflammatory bowel disease increases. With a focus on developing effective treatments to manage symptoms and induce remission, pharmaceutical companies are actively investing in research and development. The market for ulcerative colitis disease management continues to expand, offering hope to patients worldwide.

With the rising incidence and prevalence of UC globally, there's a growing demand for innovative therapies that offer improved efficacy, safety, and convenience. Biologic agents targeting specific inflammatory pathways have emerged as a mainstay of treatment for moderate to severe UC, revolutionizing disease management and providing new hope for patients who are refractory to conventional therapies. Additionally, ongoing research efforts focused on understanding the underlying pathogenesis of UC and identifying novel therapeutic targets are driving innovation in the market. As a result, the UC market is poised for continued growth, offering better treatment options and improved outcomes for patients living with this debilitating condition.

Segmentation –

Global Ulcerative Colitis Market is segmented on the basis of types and medication. Based on types, the market is segmented as ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Ulcerative proctitis is expected to command the largest market share during the forecast period. Further on the basis of medication the market is classified into 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics. Biologics are expected to command the largest market. Steroids drugs are expected to grow at the highest CAGR during the forecast period.

Regional Analysis –

The ulcerative colitis (UC) market's regional dynamics are shaped by factors like disease prevalence, access to healthcare, and treatment options. In developed regions like North America and Europe, high prevalence rates and advanced healthcare infrastructure drive market growth for UC treatments. Biologic therapies and immunosuppressants are widely available, leading to better disease management outcomes. In contrast, regions such as Asia-Pacific, Latin America, and Africa face challenges in UC management due to limited access to specialty care and higher treatment costs. However, increasing awareness of UC and government initiatives to improve healthcare access are driving market growth in these regions. Market players must adapt their strategies to address regional disparities by offering affordable treatment options, supporting patient education initiatives, and collaborating with local healthcare providers to improve UC management globally.

Key Players –

Ulcerative Colitis companies include Salix Pharmaceuticals, Abbott Laboratories, Mitsubishi Tanabe Pharma Corporation, Celgene Corporation, InDex Pharmaceuticals Holding AB, BioLineRx Ltd, Sanofi Aventis A/S, Merck & Co, Eli Lilly, and Johnson & Johnson.

Related Reports –

Protein Engineering Market Research Report - Forecast Till 2032

Dental Carpule Market Research Report - Forecast Till 2030

North American Dental Software Market Research Report - Forecast to 2030

upper GI series market research report - Forecast till 2030

For more information visit at MarketResearchFuture

[pavanpj]

"Ulcerative Colitis Therapeutics Market Analysis: Size, Share, and Emerging Trends"

 The global ulcerative colitis therapeutics market is anticipated to rise at a CAGR of 5.1% from 2021 to 2027. In 2020, revenue from ulcerative colitis therapeutics was US$ 5.6 Bn, which is expected to reach US$ 7.9 Bn by 2027.

The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing administrations. Broad rounds of essential and far reaching optional exploration have been utilized by the examiners at Fact.MR to show up at different assessments and projections for Demand of Ulcerative Colitis Therapeutics Market both at worldwide and provincial levels.

Download a Sample Copy of This Report: –https://www.factmr.com/connectus/sample?flag=S&rep_id=7286?PJ

Market Players: –

Abbott Laboratories, Inc.

AstraZeneca PLC

Avaxia Biologics, Inc.

BioLineRx Ltd.

Astellas Pharma, Inc.

Cosmo Pharmaceuticals NV

AbbVie, Inc.

Amgen, Inc.

Competitive Landscape

The market for ulcerative colitis therapeutics is highly competitive. Certain strategic efforts, such as mergers, new product launches, acquisitions, and collaborations, are implemented by key players to help them increase their market position.

For instance :

In May 2021, The U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb’s Zeposia (ozanimod) for the treatment of individuals with moderately to highly active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).

What Do You Get in a Fact.MR Study?

Factors affecting the overall development of the global Ulcerative Colitis Therapeutics Market

Factor that might restrain the growth of the global market in the coming years of the forecast period.

What is present competitive scenario of the global Ulcerative Colitis Therapeutics Market and its intricate details concerning potential business prospects of leading market players

Pricing strategies of several different market players in the global Ulcerative Colitis Therapeutics Market

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)

EU — (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe

CIS & Russia

Japan

Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)

“Innovative Therapeutics for Ulcerative Proctitis Driving Market Revenue”

The ulcerative proctitis segment is projected to record a 4.7% CAGR and reach US$ 2.1 Bn over the forecast period. One of the types of ulcerative colitis is ulcerative proctitis. Fine ulcerations in the inner linings of the large intestine mucosa are visible, and it is thought to be the first sign of ulcerative proctitis.

The segment is expected to grow due to increased research & development initiatives in the discovery of innovative therapeutics for ulcerative proctitis. Market revenue is being boosted by a growth in the number of inflammatory bowel diseases, ulcerative proctitis diseases, and the development of new ulcerative proctitis medications in clinical laboratories.

[sophiareddy123]

The report covers Global Ulcerative Colitis Market Share and the market is Segmented by Drug Type (Anti-Inflammatory Drugs (Amino salicylates, and Corticosteroids), Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Other Drug Types), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Download Free Sample Report - Ulcerative Colitis Market

[drchintamanigodbole]

What is the difference between Ulcerative Colitis and Crohn’s Disease ?

Ulcerative Colitis (UC) and Crohn's Disease are two distinct forms of inflammatory bowel disease (IBD), which are chronic inflammatory conditions that primarily affect the gastrointestinal tract. While they share some similarities, they also have significant differences in terms of their location, characteristics, and treatment approaches. Here's an overview of the key differences between Ulcerative Colitis and Crohn's Disease:

Ulcerative Colitis (UC):

Location of Inflammation: UC primarily affects the inner lining (mucosa) of the colon (large intestine) and the rectum. The inflammation in UC usually starts in the rectum and may extend continuously to involve other parts of the colon.

Pattern of Inflammation: In UC, the inflammation tends to be continuous and uniform along the affected area of the colon. It usually doesn't involve deeper layers of the intestinal wall.

Symptoms: Common symptoms of UC include bloody diarrhea, abdominal pain or cramping, urgency to have bowel movements, and rectal bleeding.

Complications: Complications of UC can include inflammation of the rectal lining (proctitis), severe inflammation and ulceration leading to perforation of the colon, and an increased risk of colon cancer after prolonged disease duration.

Surgery: Surgical removal of the colon (colectomy) is often curative in UC, as the disease is limited to the colon and rectum.

Crohn's Disease:

Location of Inflammation: Crohn's Disease can affect any part of the digestive tract, from the mouth to the anus. It can involve both the superficial and deep layers of the intestinal wall.

Pattern of Inflammation: Crohn's Disease often has a "skip" pattern, meaning that inflamed areas are interspersed with healthy areas of the intestine. It can involve all layers of the intestinal wall and create tunnels (fistulas) between different parts of the intestine or between the intestine and nearby organs.

Symptoms: Common symptoms of Crohn's Disease include abdominal pain, diarrhea (which can be watery or contain mucus), fatigue, weight loss, and sometimes rectal bleeding.

Complications: Complications of Crohn's Disease can include strictures (narrowing of the intestine due to scarring), fistulas (abnormal connections between different parts of the intestine or other organs), abscesses, and a risk of malnutrition due to impaired nutrient absorption.

Surgery: While surgery can be a treatment option for Crohn's Disease to alleviate certain complications, it's not curative as the disease can recur in other areas of the digestive tract.

It's important to note that both UC and Crohn's Disease are chronic conditions, and their symptoms can vary widely among individuals. Diagnosis involves a combination of medical history, physical examination, imaging tests, and sometimes endoscopic procedures (such as colonoscopy). Treatment approaches for both conditions may involve medications to manage inflammation, relieve symptoms, and, in some cases, surgery.

For more information, Consult Dr. Chintamani Godbole as he provides the Best Gastrointestinal Surgeon in Mumbai.

#drchintamanigodbole#colorectal surgeon in mumbai.#colon cancer treatment in mumbai

[mayank10]

*Dr. Smita Goel Homeopathy Clinic* Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly. Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission. Symptoms Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include: • Diarrhea, often with blood or pus • Abdominal pain and cramping • Rectal pain • Rectal bleeding — passing small amount of blood with stool • Urgency to defecate • Inability to defecate despite urgency • Weight loss • Fatigue • Fever • In children, failure to grow Most people with ulcerative colitis have mild to moderate symptoms. The course of ulcerative colitis may vary, with some people having long periods of remission. Types Doctors often classify ulcerative colitis according to its location. Types of ulcerative colitis include: • Ulcerative proctitis: Inflammation is confined to the area closest to the anus (rectum), and rectal bleeding may be the only sign of the disease. This form of ulcerative colitis tends to be the mildest. • Proctosigmoiditis: Inflammation involves the rectum and sigmoid colon (lower end of the colon). Signs and symptoms include bloody diarrhea, abdominal cramps and pain, and an inability to move the bowels in spite of the urge to do so (tenesmus). • Left-sided colitis: Inflammation extends from the rectum up through the sigmoid and descending colon. Signs and symptoms include bloody diarrhea, abdominal cramping and pain on the left side, and unintended weight loss. • Pancolitis: Pancolitis often affects the entire colon and causes bouts of bloody diarrhea that may be severe, abdominal cramps and pain, fatigue, and significant weight loss. • Acute severe ulcerative colitis: This rare form of colitis affects the entire colon and causes severe pain, pr (at Indirapuram Ghaziabad इंदिरापुरम गाज़ियाबाद) https://www.instagram.com/p/Cp9N62RJxvX/?igshid=NGJjMDIxMWI=

[dr-smita-goel-homeopathy-clinic]

*Dr. Smita Goel Homeopathy Clinic*

www.thehomeopathyclinic.co.in

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.

Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission.

Symptoms

Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:

• Diarrhea, often with blood or pus

• Abdominal pain and cramping

• Rectal pain

• Rectal bleeding — passing small amount of blood with stool

• Urgency to defecate

• Inability to defecate despite urgency

• Weight loss

• Fatigue

• Fever

• In children, failure to grow

Most people with ulcerative colitis have mild to moderate symptoms. The course of ulcerative colitis may vary, with some people having long periods of remission.

Types

Doctors often classify ulcerative colitis according to its location. Types of ulcerative colitis include:

• Ulcerative proctitis: Inflammation is confined to the area closest to the anus (rectum), and rectal bleeding may be the only sign of the disease. This form of ulcerative colitis tends to be the mildest.

• Proctosigmoiditis: Inflammation involves the rectum and sigmoid colon (lower end of the colon). Signs and symptoms include bloody diarrhea, abdominal cramps and pain, and an inability to move the bowels in spite of the urge to do so (tenesmus).

• Left-sided colitis: Inflammation extends from the rectum up through the sigmoid and descending colon. Signs and symptoms include bloody diarrhea, abdominal cramping and pain on the left side, and unintended weight loss.

• Pancolitis: Pancolitis often affects the entire colon and causes bouts of bloody diarrhea that may be severe, abdominal cramps and pain, fatigue, and significant weight loss.

• Acute severe ulcerative colitis: This rare form of colitis affects the entire colon and causes severe pain, profuse diarrhea, bleeding, fever and inability to eat.

When to see a doctor

See your doctor if you experience a persistent change in your bowel habits or if you have signs and symptoms such as:

• Abdominal pain

• Blood in your stool

• Ongoing diarrhea that doesn't respond to over-the-counter medications

• Diarrhea that awakens you from sleep

• An unexplained fever lasting more than a day or two

Although ulcerative colitis usually isn't fatal, it's a serious disease that, in some cases, may cause life-threatening complications.

Causes

The exact cause of ulcerative colitis remains unknown. Previously, diet and stress were suspected, but now doctors know that these factors may aggravate but don't cause ulcerative colitis.

One possible cause is an immune system malfunction. When your immune system tries to fight off an invading virus or bacterium, an abnormal immune response causes the immune system to attack the cells in the digestive tract, too.

Heredity also seems to play a role in that ulcerative colitis is more common in people who have family members with the disease. However, most people with ulcerative colitis don't have this family history.

Risk factors

Ulcerative colitis affects about the same number of women and men. Risk factors may include:

• Age: Ulcerative colitis usually begins before the age of 30. But, it can occur at any age, and some people may not develop the disease until after age 60.

• Race or ethnicity: Although whites have the highest risk of the disease, it can occur in any race. If you're of Ashkenazi Jewish descent, your risk is even higher.

• Family history: You're at higher risk if you have a close relative, such as a parent, sibling or child, with the disease.

Complications

Possible complications of ulcerative colitis include:

• Severe bleeding

• A hole in the colon (perforated colon)

• Severe dehydration

• Liv0065Rr disease (rare)

• Bone loss (osteoporosis)

• Inflammation of your skin, joints and eyes

• An increased risk of colon cancer

• A rapidly swelling colon (toxic megacolon)

• Increased risk of blood clots in veins and arteries

[mcatmemoranda]

Blood in stool

Definition and diagnostic implications – The term minimal bright red blood per rectum (BRBPR) is used to indicate small amounts of red blood on toilet paper after wiping or a few drops of blood in the toilet bowl after defecation. Small amounts of blood on the surface of the stool is also considered minimal BRBPR, but red blood intermixed with stool is not. Minimal BRBPR suggests a lesion near the anal canal but must be differentiated from a history of melena (which implies upper gastrointestinal or slow proximal colonic bleeding) or maroon stool with intermixed bright red blood. (See 'Definition' above.)

●Etiologies – Common causes of BRBPR include hemorrhoids, anal fissures, polyps, proctitis, rectal ulcers, and colorectal cancer. Diverticulosis is generally an incidental finding, since diverticular bleeding is usually of greater volume. (See 'Etiologies' above.)

●Clinical assessment – The goal of the clinical assessment for patients who present with BRBPR is to identify those who are at risk for a serious cause of bleeding and who therefore require additional testing; discriminating such patients can be challenging. The history should be directed to the type of bleeding pattern, systemic symptoms, age, family history, and known bowel conditions. The physical examination should include a digital rectal examination and, when possible, office-based anoscopy or proctoscopy. (See 'Clinical assessment' above.)

●Approach to diagnostic testing – Diagnostic testing for selected patients may involve either colonoscopy or sigmoidoscopy. Computed tomographic colonography (CTC) is not an appropriate initial investigation but may be useful when colonoscopy is incomplete or contraindicated. (See 'Diagnostic tests' above.)

•The decision whether to do colonoscopy or sigmoidoscopy may be based on the patient’s age and risks for colorectal carcinoma. We consider flexible sigmoidoscopy to be an alternative first line of investigation in patients with unexplained bleeding up to the age of 49 years; the choice of test in this group may be influenced by cost and availability of the procedure. (See 'Sigmoidoscopy versus colonoscopy' above.)

•The following signs and symptoms are considered “red flags” and indications for additional testing: melena, constitutional symptoms, change in bowel frequency or caliber, or a family history of a colon cancer syndrome.

•In the absence of red flags, we generally advise colonoscopy for patients with BRBPR who are age 50 and older; sigmoidoscopy or colonoscopy for patients 40 to 49 years of age; and, for patients younger than 40 years, no further evaluation if a source of bleeding is identified on physical examination, and sigmoidoscopy (or colonoscopy) if a bleeding source is not identified. (See 'Approach to the patient' above.)

●Persistent or recurrent bleeding – Patients with persistent or recurrent bleeding should undergo colonoscopy at least once and be periodically reassessed for any change in symptoms or development of red flags. (See 'Persistent bleeding' above.)

[iamtheendofrainbow]

Shout out

to all the people suffering from IBD who always have to tell their friends that they have a “relapse” because they never look sick but also they can’t really speak about the symptoms cause it’s just too gross and embarassing to talk about

[homoeocare]

“It’s auto-immune, Nobody did anything wrong. It’s your body doing it to itself”

ULCERATIVE COLITIS

It is one of the chronic auto-immune diseases which come under the category of an inflammatory bowel disease (IBD).

It causes long-lasting inflammation and the sores (ulcers) in the digestive tract.

It chiefly affects the inner lining of the large intestine, the colon and the rectum.

It will be life-threatening if not treated on time.

TYPES OF ULCERATIVE COLITIS

Ulcerative proctitis: Inflammation is only in the region around the anus (rectum) and the rectum bleeding.

Proctosigmoiditis: Bloody diarrhea, cramps and pain in the abdomen, unable to move the bowels.

Left-sided colitis: Unexplained weight loss, severe pain on the left side of the colon alongwith the bloody diarrhea and cramping.

Pancolitis: Extreme Fatigue, pain & cramping with the weight loss.

Acute severe ulcerative colitis: Rarely happens with severe bleeding, pain, fever, profuse diarrhea & inability to eat.

SYMPTOMS

Cramps in abdomen

Fatigue

Fever

Rectal pain

Weight loss

Rectal bleeding

Anemia

Diarrhea

Eye pain

Joint pain

Feeling no hunger at all

Not being able to hold your stool in

 Abdominal pain

CAUSES

Diet & stress

Immune system malfunctioning

Heredity

RISK FACTORS

Age

Race

Family history

Genes

Immune disorders

Environmental factors

COMPLICATIONS

Excessive bleeding

Dehydration

Bone loss

Rapid swelling in the colon

Hole in the colon

Inflammation of eyes, joints & skin

Extreme risk of blood clots in the veins & the arteries

Increased risk of colon cancer

Ulcerative collitis is curable by HomoeoCARE

Being mild it tends to modify the body’s natural immunity.

It repairs the damage occurred due to the bacteria or viruses.

It helps in moderating the overactive immune system.

It is based on individual case analysis.

It helps in reducing the severity and frequency of flare-ups.

It helps in managing the loose stool, blood, abdominal cramping and rectal pain.

WE CARE FOR YOU

Call us at 8727003555